On May 10, 2022 Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") reported that its management team will participate in the following upcoming investor conferences and events (Press release, Calliditas Therapeutics, MAY 10, 2022, View Source [SID1234614045]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The 8th Annual LSX World Congress on May 10-11, 2022 in London, United Kingdom
The ABGSC Life Science Summit on May 18–19, 2022, in Stockholm, Sweden.
H.C. Wainwright Hybrid Global Investment Conference on May 23-26, 2022.
Jefferies Healthcare Conference on June 8-10, 2022 in New York City, USA.
Citi European Healthcare Conference on June 14–16, 2022 in London, United Kingdom
At the LSX World Congress, Calliditas Chief Executive Officer Renée Aguiar-Lucander, Chief Financial Officer Fredrik Johansson and President of North America, Andrew Udell will speak in three separate panel discussions focused on global commercial strategy, IPO listings, and product launching, respectively.
Renee Aguiar-Lucander will present at the ABGSC Life Science Summit on May 19th at 11:30am to 12pm CET.
Management will be presenting and will host one-on-one investor meetings at the other three conferences. To schedule a one-on-one meeting with Calliditas, please contact your representative at H.C Wainwright, Jefferies, or Citi.
The information was sent for publication, through the agency of the contact persons set out above, on May 10, 2022 at 8:30 a.m. CET.